Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:CIK NYSE:ECC NYSE:HQL NYSE:IFN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIKCredit Suisse Asset Management Income Fund$2.47$2.54$2.44▼$3.04$135.50M0.56664,128 shs816,080 shsECCEagle Point Credit$3.69+0.7%$4.02$3.46▼$7.83$487.19M0.351.01 million shs1.09 million shsHQLabrdn Life Sciences Investors$18.00+0.2%$17.52$12.34▼$18.46$547.29M0.78101,468 shs120,520 shsIFNIndia Fund$11.72+0.1%$11.58$10.72▼$16.60$499.77M0.69171,554 shs153,721 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIKCredit Suisse Asset Management Income Fund-0.40%-1.59%-1.20%-2.37%-13.64%ECCEagle Point Credit+1.94%-3.41%-8.45%+0.55%-51.09%HQLabrdn Life Sciences Investors+1.08%+7.09%+3.77%+11.00%+42.78%IFNIndia Fund+1.59%+7.82%+1.59%+3.33%-26.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIKCredit Suisse Asset Management Income Fund$2.47$2.54$2.44▼$3.04$135.50M0.56664,128 shs816,080 shsECCEagle Point Credit$3.69+0.7%$4.02$3.46▼$7.83$487.19M0.351.01 million shs1.09 million shsHQLabrdn Life Sciences Investors$18.00+0.2%$17.52$12.34▼$18.46$547.29M0.78101,468 shs120,520 shsIFNIndia Fund$11.72+0.1%$11.58$10.72▼$16.60$499.77M0.69171,554 shs153,721 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIKCredit Suisse Asset Management Income Fund-0.40%-1.59%-1.20%-2.37%-13.64%ECCEagle Point Credit+1.94%-3.41%-8.45%+0.55%-51.09%HQLabrdn Life Sciences Investors+1.08%+7.09%+3.77%+11.00%+42.78%IFNIndia Fund+1.59%+7.82%+1.59%+3.33%-26.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCIKCredit Suisse Asset Management Income Fund 0.00N/AN/AN/AECCEagle Point Credit 2.60Moderate Buy$6.5076.39% UpsideHQLabrdn Life Sciences Investors 0.00N/AN/AN/AIFNIndia Fund 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CIK, HQL, ECC, and IFN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/1/2026ECCEagle Point Credit Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/15/2026ECCEagle Point Credit Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy(Data available from 6/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCIKCredit Suisse Asset Management Income FundN/AN/AN/AN/AN/AN/AECCEagle Point Credit$203.99M2.39N/AN/A$5.94 per share0.62HQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/AIFNIndia FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCIKCredit Suisse Asset Management Income FundN/AN/AN/AN/AN/AN/AN/AN/AN/AECCEagle Point Credit-$115M$0.953.885.19N/A12.33%13.47%8.14%8/18/2026 (Estimated)HQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/AN/AN/AN/AIFNIndia FundN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest CIK, HQL, ECC, and IFN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026ECCEagle Point Credit$0.2267$0.20-$0.0267-$1.12$48.79 million$42.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCIKCredit Suisse Asset Management Income Fund$0.2610.53%N/AN/AN/AECCEagle Point Credit$1.4439.08%+6.26%151.58%N/AHQLabrdn Life Sciences Investors$2.0411.34%N/AN/AN/AIFNIndia Fund$2.1818.60%N/AN/AN/ALatest CIK, HQL, ECC, and IFN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/12/2026ECCEagle Point Creditmonthly$0.0617.63%9/10/20269/10/20269/30/20265/12/2026ECCEagle Point Creditmonthly$0.0617.63%8/11/20268/11/20268/31/20265/12/2026ECCEagle Point Creditmonthly$0.0617.63%7/13/20267/13/20267/31/20265/11/2026HQLabrdn Life Sciences Investorsquarterly$0.5613.02%5/21/20265/21/20266/30/20265/11/2026IFNIndia Fundquarterly$0.3913.69%5/21/20265/21/20266/30/20266/1/2026CIKCredit Suisse Asset Management Income Fundmonthly$0.029.72%6/15/20266/15/20266/23/20265/11/2026HQLabrdn Life Sciences Investorsquarterly$0.5612.35%5/21/20265/21/20265/30/20265/11/2026IFNIndia Fundquarterly$0.3913.22%5/21/20265/21/20265/30/20265/1/2026CIKCredit Suisse Asset Management Income Fundmonthly$0.029.6%5/15/20265/15/20265/22/20264/1/2026CIKCredit Suisse Asset Management Income Fundmonthly$0.029.3%4/16/20264/16/20264/23/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCIKCredit Suisse Asset Management Income FundN/AN/AN/AECCEagle Point Credit0.020.230.23HQLabrdn Life Sciences InvestorsN/AN/AN/AIFNIndia FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCIKCredit Suisse Asset Management Income Fund29.49%ECCEagle Point Credit19.50%HQLabrdn Life Sciences Investors32.21%IFNIndia Fund10.76%Insider OwnershipCompanyInsider OwnershipCIKCredit Suisse Asset Management Income Fund18.63%ECCEagle Point Credit0.26%HQLabrdn Life Sciences Investors10.06%IFNIndia FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCIKCredit Suisse Asset Management Income Fund654.86 million44.64 millionNot OptionableECCEagle Point CreditN/A132.21 million131.87 millionNot OptionableHQLabrdn Life Sciences InvestorsN/A30.41 million27.35 millionNot OptionableIFNIndia Fund21,00042.65 millionN/ANot OptionableCIK, HQL, ECC, and IFN HeadlinesRecent News About These CompaniesCertain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and AmountsMay 11, 2026 | prnewswire.comIFN: Rising Crude Pressures Equities While Currency Depreciation Drags On USD ReturnsMarch 24, 2026 | seekingalpha.comL Catterton's India Fund I hits $200 million markMarch 17, 2026 | newsbytesapp.comNThe India Fund, Inc. Q4 2025 CommentaryMarch 3, 2026 | seekingalpha.comStartup India Fund of Funds 2.0 ApprovedFebruary 13, 2026 | money.rediff.comMCertain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and AmountsFebruary 10, 2026 | prnewswire.comGovernment proposes to top up Self Reliant India Fund with Rs 4,000 crore in 2026-27 to support MSMEsFebruary 1, 2026 | newindianexpress.comSelf-Reliant India Fund: Rs 4,000 Cr Top-Up for MSMEsFebruary 1, 2026 | money.rediff.comMBudget 2026: Self-Reliant India Fund to get additional ₹4,000 crore to bolster MSMEsFebruary 1, 2026 | msn.comBudget 2026-27: Sitharaman proposes Rs 4,000 for Self-Reliant India Fund to support MSMEsFebruary 1, 2026 | firstpost.comFIFN: Indian Stock Market Correction Set To Continue As Headwinds Remain In 2026January 21, 2026 | seekingalpha.comTHE INDIA FUND, INC. (IFN) ANNOUNCES A 20% INCREASE TO ITS MANAGED DISTRIBUTION POLICYDecember 9, 2025 | prnewswire.comKSH International raised fund via pre-IPO placement from Malabar India Fund & othersDecember 9, 2025 | msn.comSBI Funds, DSP India Fund, Think India Opportunities Fund invest Rs. 144 cr in Aequs Ltd. in pre-IPO placement dealNovember 12, 2025 | equitybulls.comEAequs raises ₹144 crore from SBI, DSP, Think India Funds ahead of IPONovember 11, 2025 | thehindubusinessline.comSBI Funds, DSP India Fund, Think India Invest ₹ 144 Cr in Aequs in Pre-IPO RoundNovember 11, 2025 | msn.comIndia regulator bars mutual funds from investing in pre-IPO placements, sources sayOctober 24, 2025 | msn.comBaron India FundOctober 21, 2025 | money.usnews.comIFN: Still A Buy, But With CaveatsOctober 20, 2025 | seekingalpha.comMutual Fund Growth Reveals Deep Divide in Indian Investment LandscapeOctober 17, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCIK, HQL, ECC, and IFN Company DescriptionsCredit Suisse Asset Management Income Fund NYSEAMERICAN:CIK$2.47 0.00 (0.00%) Closing price 06/18/2026 04:10 PM EasternExtended Trading$2.46 -0.01 (-0.20%) As of 06/18/2026 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Credit Suisse Asset Management Income Fund, Inc. is a closed-ended fixed income mutual fund launched and managed by Credit Suisse Asset Management, LLC. The fund invests in the fixed income markets of the United States. It primarily invests in high yield corporate debt such as bonds and debentures that are rated Baa or lower by Moody's or BBB or lower by S&P. The fund benchmarks the performance of its portfolio against the BofA Merrill Lynch US High Yield Master II Constrained Index. Credit Suisse Asset Management Income Fund, Inc. was formed on February 11, 1987 and is domiciled in the United States.Eagle Point Credit NYSE:ECC$3.68 +0.03 (+0.68%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$3.68 -0.01 (-0.27%) As of 06/18/2026 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.abrdn Life Sciences Investors NYSE:HQL$18.00 +0.04 (+0.21%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$17.98 -0.02 (-0.09%) As of 06/18/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.India Fund NYSE:IFN$11.72 +0.01 (+0.07%) Closing price 06/18/2026 03:58 PM EasternExtended Trading$11.77 +0.06 (+0.48%) As of 06/18/2026 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The India Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund invests in public equity markets of India. It seeks to invest in stocks of small-cap, mid-cap, and large-cap companies. The fund employs a quantitative and fundamental analysis with a bottom-up stock picking and asset allocation approach to create its portfolio. It benchmarks the performance of its portfolio against the IFC Investable India Index. The India Fund, Inc. was formed on December 27, 1993 and is domiciled in the Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate American Eagle’s Q1 Beat Leaves Investors With a Bigger Question Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
